These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34961945)

  • 21. Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?
    Flamholz R; Jeon HR; Baron JM; Baron BW
    J Clin Apher; 2000; 15(3):169-72. PubMed ID: 10962468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura.
    Moake J; Chintagumpala M; Turner N; McPherson P; Nolasco L; Steuber C; Santiago-Borrero P; Horowitz M; Pehta J
    Blood; 1994 Jul; 84(2):490-7. PubMed ID: 8025277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAMTS-13 levels in fresh, stored, and solvent detergent treated plasma.
    Rock G; Yousef H; Neurath D; Lu M
    Transfus Apher Sci; 2006 Dec; 35(3):235-8. PubMed ID: 17112784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of Fresh Frozen Plasma and Cryosupernatant Plasma for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Institution Experience.
    Lin Q; Fan L; Huang H; Zeng F; Fu D; Wei S
    Biomed Res Int; 2019; 2019():1756109. PubMed ID: 30834255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
    Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
    Mintz PD; Neff A; MacKenzie M; Goodnough LT; Hillyer C; Kessler C; McCrae K; Menitove JE; Skikne BS; Damon L; Lopez-Plaza I; Rouault C; Crookston KP; Benjamin RJ; George J; Lin JS; Corash L; Conlan MG
    Transfusion; 2006 Oct; 46(10):1693-704. PubMed ID: 17002625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of solvent/detergent-treated plasma in patients with a prolonged prothrombin time.
    Lerner RG; Nelson J; Sorcia E; Grima K; Kancherla RR; Zarou-Naimo CM; Pehta JC
    Vox Sang; 2000; 79(3):161-7. PubMed ID: 11111235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy.
    Novitzky N; Thomson J; Abrahams L; du Toit C; McDonald A
    Br J Haematol; 2005 Feb; 128(3):373-9. PubMed ID: 15667540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes and progress in the treatment of TTP--protocols of therapeutic plasma infusion and plasma exchange--therapeutic results by the Japanese and Canadian Study Groups].
    Ito K; Hattori A; Hirosawa S; Takamatsu J; Kakishita E; Fujimura K
    Nihon Rinsho; 1993 Jan; 51(1):184-6. PubMed ID: 8433516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solvent/detergent-treated plasma: composition, efficacy, and safety.
    Hellstern P
    Curr Opin Hematol; 2004 Sep; 11(5):346-50. PubMed ID: 15666659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic plasma exchange in the treatment of the hereditary thrombotic thrombocytopenic purpura].
    Cermáková Z; Korístka M; Korístková B; Hrdlicková R; Suláková T; Furková J; Kovárová P
    Cas Lek Cesk; 2009; 148(10):493-6. PubMed ID: 20662412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.
    Moake JL; Byrnes JJ; Troll JH; Rudy CK; Hong SL; Weinstein MJ; Colannino NM
    Blood; 1985 May; 65(5):1232-6. PubMed ID: 3873262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of virus-inactivated plasma in apheresis treatment of thrombotic thrombocytopenic purpura: preliminary data].
    Russi G; De Silvestro G; Savignano C;
    G Ital Nefrol; 2012; 29 Suppl 54():S49-53. PubMed ID: 22388830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.
    Rock GA; Shumak KH; Buskard NA; Blanchette VS; Kelton JG; Nair RC; Spasoff RA
    N Engl J Med; 1991 Aug; 325(6):393-7. PubMed ID: 2062330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet transfusion in thrombotic thrombocytopenic purpura.
    Otrock ZK; Liu C; Grossman BJ
    Vox Sang; 2015 Aug; 109(2):168-72. PubMed ID: 25900398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura.
    Scully M; Longair I; Flynn M; Berryman J; Machin SJ
    Vox Sang; 2007 Aug; 93(2):154-8. PubMed ID: 17683359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group.
    Rock G; Shumak KH; Sutton DM; Buskard NA; Nair RC
    Br J Haematol; 1996 Aug; 94(2):383-6. PubMed ID: 8759902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative concentrations of haemostatic factors and cytokines in solvent/detergent-treated and fresh-frozen plasma.
    Theusinger OM; Baulig W; Seifert B; Emmert MY; Spahn DR; Asmis LM
    Br J Anaesth; 2011 Apr; 106(4):505-11. PubMed ID: 21310721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
    Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
    Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All plasma products are not created equal: Characterizing differences between plasma products.
    Spinella PC; Frazier E; Pidcoke HF; Dietzen DJ; Pati S; Gorkun O; Aden JK; Norris PJ; Cap AP
    J Trauma Acute Care Surg; 2015 Jun; 78(6 Suppl 1):S18-25. PubMed ID: 26002258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.